Edwards Lifesciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,068	5,440	5,010	4,464	5,233
Revenue Growth (YoY)	11.55%	8.57%	12.23%	-14.69%	19.29%
Cost of Revenue	1,334	1,118	978.4	723.7	1,249
Gross Profit	4,733	4,322	4,032	3,740	3,984
Selling, General & Admin	2,085	1,789	1,583	1,358	1,494
Research & Development	1,079	1,053	962.9	843.6	903.1
Other Operating Expenses	304.8	101.1	177.3	40.7	-103.5
Total Operating Expenses	3,469	2,943	2,723	2,242	2,293
Operating Income	1,264	1,379	1,309	1,498	1,690
Interest Income	168.8	120.3	67.2	35.5	17.4
Interest Expense	-20.4	-19.8	-17.6	-19.2	-18.4
Other Non-Operating Income (Expense)	-139.7	68.9	13.9	4.8	12.7
Total Non-Operating Income (Expense)	8.7	169.4	63.5	21.1	11.7
Pretax Income	1,273	1,548	1,372	1,520	1,702
Provision for Income Taxes	216.9	152.1	152.4	195.5	198.9
Net Income	1,074	4,175	1,402	1,522	1,503
Minority Interest in Earnings	-4.1	-4.9	-3	-	-
Earnings From Discontinued Operations	13.4	2,774	179.4	197.9	-
Net Income to Common	1,074	4,175	1,402	1,522	1,503
Net Income Growth	-74.28%	197.68%	-7.85%	1.25%	82.55%
Shares Outstanding (Basic)	585	598	607	619	623
Shares Outstanding (Diluted)	586	599	609	624	631
Shares Change (YoY)	-2.25%	-1.66%	-2.37%	-1.11%	-0.11%
EPS (Basic)	1.84	6.98	2.31	2.46	2.41
EPS (Diluted)	1.83	6.97	2.30	2.44	2.38
EPS Growth	-73.75%	203.04%	-5.74%	2.52%	83.08%
Shares Outstanding	580.7	588.6	601.1	608.3	624.1
Free Cash Flow	1,335	289.9	642.8	973.6	1,406
Free Cash Flow Growth	360.50%	-54.90%	-33.98%	-30.77%	117.26%
Free Cash Flow Per Share	2.28	0.48	1.05	1.56	2.23
Gross Margin	78.01%	79.46%	80.47%	83.79%	76.13%
Operating Margin	20.84%	25.35%	26.13%	33.57%	32.30%
Profit Margin	35.03%	102.32%	52.28%	63.75%	28.73%
FCF Margin	22.00%	5.33%	12.83%	21.81%	26.88%
EBITDA	1,421	1,534	1,454	1,638	1,825
EBITDA Margin	23.42%	28.20%	29.02%	36.69%	34.88%
EBIT	1,264	1,379	1,309	1,498	1,690
EBIT Margin	20.84%	25.35%	26.13%	33.57%	32.30%
Effective Tax Rate	17.04%	9.82%	11.10%	12.87%	11.69%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q